Welcome back to the EUCVC Summit Talks, where we bring you candid conversations with Europe’s leading founders, corporate leaders, and investors shaping the future of venture collaboration.
In this episode, Anne C. Fleischer, Global VP of Consumer Engagement and New Business Models at Novo Nordisk, joins Henrijette Richter, Managing Partner at Sofinnova Partners, for a conversation on the future of health innovation.
Together they explore how corporates and VCs are driving the next wave of digital health, the role of AI in transforming patient care, and what it takes to turn breakthrough science into scalable business models.
🎧 Here’s what’s covered:
00:00 Pharma’s digital leap — why Novo Nordisk is going “beyond the pill” with AI and personalized engagement.
01:30 The investor’s lens — what makes AI-driven health fundable versus “still a science project”.
03:00 AI at the patient interface — where machine learning is closest to real-world integration.
04:30 Corporate + VC collaboration — how pharma and venture can align (and where they clash).
06:00 Scaling deeptech in health — what it takes for startups to go global from day one.
07:30 Consumerization of health — balancing trust, privacy, and the impatience economy.
08:45 Europe’s edge — strengths in science and regulation, risks of falling behind the U.S..
09:30 Lightning round — the next big thing in health innovation: specificity for patients.
